Middle East And Africa Intravenous Ibuprofen Market By Age Group (adults And Paediatrics) , By Indication ( Fever And Pain/inflammatory) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts(2017–2022)

Middle East And Africa Intravenous Ibuprofen Market By Age Group (adults And Paediatrics) , By Indication ( Fever And Pain/inflammatory) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts(2017–2022)

ID: 6739 | Pages: 145 | March 2018 | Region: Middle East and Africa


Middle East and Africa Intravenous Ibuprofen Market was worth USD 343.2 million in 2017 and estimated to be growing at a CAGR of 19.75%, to reach USD 845.13 million by 2022. Ibuprofen is a Non steroidal anti-Inflammatory drug used to treat pain and fever which can be causative of a disease, trauma or any major operation. In an intravenous form, the drug has a faster onset of action as compared to other forms. IV Ibuprofen is used to manage acute and post-operative pain.

Due to its faster onset of action and fast results, the market is expected to grow at a rapid rate during the forecast period. As it has been approved for paediatric use, the market is further expected to propel. Due to increased incidence of cardiovascular diseases, cancer and fever coupled with shifting trend to non-opoid drugs is further driving the market growth. However, the side effects associated with the use of ibuprofen and the lengthy approval processes are hampering the market growth.

The market for Intravenous Ibuprofen is broadly categorized into age group and indication. By age group the market is divided into adults and paediatrics. Adults are the major consumer base for intravenous ibuprofen. The paediatric segment is expected to grow at a substantial rate. By indication the market is further classified into fever and pain/inflammatory. Fever is projected to be the fastest growing segment. On the basis of geography, the market is analysed under various regions namely Middle East and Africa.

Some of the major companies dominating the market, by their products and services include Cumberland Pharmaceuticals Inc., Alveda Pharmaceuticals, Inc., CSL Limited, Sandor Medicaids Pvt Ltd., Germin MED, Grifols S.A., Harbin Gloria Pharmaceuticals Co., Ltd., Al Nabeel International Ltd., PT. Soho Industri Pharmasi, and Laboratorios Valmorca, C.A.

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1          Age group                                          

                                5.1.1 Introduction                                           

                                5.1.2 Paediatrics                                              

                                5.1.3 Adults                                       

                                5.1.4  Y-o-Y Growth Analysis, By age group                                          

                                5.1.5  Market Attractiveness Analysis, By age group                                        

                                5.1.6  Market Share Analysis, By age group                                          

                5.2          Indication                                           

                                5.2.1 Introduction                                           

                                5.2.2 Pain/inflammatory                                              

                                5.2.3 Fever                                         

                                5.2.4 Y-o-Y Growth Analysis, By Indication                                           

                                5.2.5 Market Attractiveness Analysis, By Indication                                         

                                5.2.6 Market Share Analysis, By Indication                                           

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                                6.1.3.1 By Geographical Area                     

                                                6.1.3.2 By age group                      

                                                6.1.3.3 By indication                       

                                6.1.4  Market Attractiveness Analysis                                     

                                                6.1.4.1 By Geographical Area                     

                                                6.1.4.2 By age group                      

                                                6.1.4.3 By indication                       

                                6.1.5  Market Share Analysis                                      

                                                6.1.5.1 By Geographical Area                     

                                                6.1.5.2 By age group                      

                                                6.1.5.3 By indication                       

                6.2 Middle-East                                                                

                6.3 Africa                                                            

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                                                                        

                8.1 Cumberland Pharmaceuticals Inc.                                                     

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Alveda Pharmaceuticals, Inc.                                                              

                8.3 CSL Limited                                                 

                8.4 Sandor Medicaids Pvt Ltd.                                                    

                8.5 Germin MED                                                              

                8.6 Grifols S.A.                                                  

                8.7 Harbin Gloria Pharmaceuticals Co.Ltd.                                                            

                8.8 Al Nabeel International Ltd.                                                

                8.9 Laboratorios Valmorca, C.A.                                                

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10. Market Outlook and Investment Opportunities                                                                         

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Age group, by Indication along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

                                                                                                                          

TitlePriceAdd To Cart
  1. Middle East and Africa Intravenous Ibuprofen  Market By Age group, From 2016-2022 ( USD Billion )
  2. Middle East and Africa Paediatric Market By Region, From 2016-2022 ( USD Billion )
  3. Middle East and Africa Adults Market By Region, From 2016-2022 ( USD Billion )
  4. Middle East and Africa Intravenous Ibuprofen  Market By Indication, From 2016-2022 ( USD Billion )
  5. Middle East and Africa Pain/inflammatory Market By Region, From 2016-2022 ( USD Billion )
  6. Middle East and Africa Fever Market By Region, From 2016-2022 ( USD Billion )
  7. Middle East and Africa Intravenous Ibuprofen  Market By Distribution channel, From 2016-2022 ( USD Billion )
  8. Middle East and Africa Supermarket and hypermarkets Market By Region, From 2016-2022 ( USD Billion )
  9. Middle East and Africa Convenience stores Market By Region, From 2016-2022 ( USD Billion )
  10. Middle East and Africa Specialty stores Market By Region, From 2016-2022 ( USD Billion )
  11. Middle East and Africa Online sale Market By Region, From 2016-2022 ( USD Billion )
  12. Middle East Intravenous Ibuprofen  Market By Age group, From 2016-2022 ( USD Billion )
  13. Middle East Intravenous Ibuprofen  Market By Indication, From 2016-2022 ( USD Billion )
  14. Middle East Intravenous Ibuprofen  Market By Distribution channel, From 2016-2022 ( USD Billion )
  15. Africa Intravenous Ibuprofen  Market By Age group, From 2016-2022 ( USD Billion )
  16. Africa Intravenous Ibuprofen  Market By Indication, From 2016-2022 ( USD Billion )
  17. Africa Intravenous Ibuprofen  Market By Distribution channel, From 2016-2022 ( USD Billion )
Middle East And Africa Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, G...
Latin America Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Tr...
Asia Pacific Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Tre...
Europe Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, A...
North America Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Tr...
Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Fore...
Middle East And Africa Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extre...
Latin America Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepi...
Asia Pacific Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepin...
Europe Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepiness, C...
North America Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepi...
Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepiness, Cataplex...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.